Telomerase, p53 and PCNA activity in osteosarcoma

被引:6
|
作者
Nakashima, H
Nishida, Y
Sugiura, H
Katagiri, H
Yonekawa, M
Yamada, Y
Iwata, H
Nagasaka, T
Ishiguro, N
机构
[1] Nagoya Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 466, Japan
[2] Nagoya Univ, Sch Med, Dept Pathol, Nagoya, Aichi 466, Japan
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2003年 / 29卷 / 07期
关键词
telomerase activity; p53; PCNA; osteosarcoma;
D O I
10.1016/S0748-7983(03)00117-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The aim of this study was to investigate telomerase activity and to assess the correlation between telomerase activity, tumor proliferative activity and p53 overexpression in osteosarcoma tumor samples. Methods: Using a telomerase polymerase chain reaction-enzyme-linked immunoassay based on the telomeric repeat amplification protocol method, we examined telomerase activity in 26 primary osteosarcoma specimens. P53 overexpression was identified using immunohistochemical staining, and tumor proliferative activity was assessed by immunohistochemical staining of PCNA. Results: Telomerase activity was detected at a relatively low level in five of 26 osteosarcoma tissue specimens. P53 was detected in eight of 21 cases. There was no significant correlation between telomerase activity and p53 overexpression (p = 0.325). There was a significant correlation between PCNA staining and telomerase activity (p = 0.0075). Conclusion: Difference between the telomerase activity and p53 overexpression in osteosarcoma suggests that p53 and telomerase may not cooperate in tumor proliferation. Correlation of telomerase activity to PCNA expression suggests that telomerase activity may also useful for evaluate proliferative activity in osteosarcoma. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:564 / 567
页数:4
相关论文
共 50 条
  • [41] PCNA and p53 X histologycal grade of malignancy in OSCC
    Alves, ATNN
    Freitas, RA
    Queirós, LMG
    [J]. JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1072 - 1072
  • [42] Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis
    Batheja, N
    Suriawinata, A
    Saxena, R
    Ionescu, G
    Schwartz, M
    Thung, SN
    [J]. MODERN PATHOLOGY, 2000, 13 (12) : 1265 - 1268
  • [43] Spatial repression of PCNA by p53 during kidney development
    Saifudeen, Z
    Marks, J
    Du, H
    El-Dahr, SS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (04) : F727 - F733
  • [44] p53、PCNA在胃癌中的表达
    郑维锷
    孙利敏
    林讷
    [J]. 肿瘤学杂志, 2006, (02) : 160 - 160
  • [45] p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
    Qin, LF
    Ng, IOL
    Fan, ST
    Ng, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (04) : 424 - 428
  • [46] FREQUENCY AND STRUCTURE OF P53 REARRANGEMENTS IN HUMAN OSTEOSARCOMA
    MILLER, CW
    ASLO, A
    TSAY, C
    SLAMON, D
    ISHIZAKI, K
    TOGUCHIDA, J
    YAMAMURO, T
    LAMPKIN, B
    KOEFFLER, HP
    [J]. CANCER RESEARCH, 1990, 50 (24) : 7950 - 7954
  • [47] Correlation between osteosarcoma and the expression of WWOX and p53
    Liu, Pingtao
    Wang, Mingyue
    Li, Li
    Jin, Tao
    [J]. ONCOLOGY LETTERS, 2017, 14 (04) : 4779 - 4783
  • [48] p53 isoforms can regulate p53 transcriptional activity
    Bourdon, JC
    Fernandes, K
    Murray-Zmijewski, F
    Liu, G
    Diot, A
    Xirodimas, DP
    Saville, MK
    Lane, DP
    [J]. GENES & DEVELOPMENT, 2005, 19 (18) : 2122 - 2137
  • [49] P53 regulation and activity
    Meek, David W.
    [J]. TOXICOLOGY, 2007, 240 (03) : 133 - 134
  • [50] p53 activity and chemotherapy
    Delia, D
    Mizutani, S
    Lamorte, G
    Goi, K
    Iwata, S
    Pierotti, MA
    [J]. NATURE MEDICINE, 1996, 2 (07) : 724 - 725